Perioperative aspirin for non-cardiac surgery increases risk for major bleeds
4/02/2014
Patients given aspirin to prevent heart problems after non-heart-related surgery had a higher risk of serious bleeding than the patients who did not receive aspirin. At the same time, aspirin did not reduce incidence of post-operative heart attacks and death, according to data from POISE-2 presented at the American College of Cardiology's 63rd Annual Scientific Session.
Why The Sun newspaper breast check campaign may actually harm women
4/02/2014
A breast check campaign by The Sun newspaper may actually harm women, warns Glasgow GP Margaret McCartney on bmj.com.The "check 'em Tuesday" campaign is a weekly call for women to examine their breasts. Readers are asked to send in photos to prove compliance and can even sign up for a text message reminder.
'Eat seven portions of fruit and veg a day' to lower death risk
4/01/2014
The results of a study published in the Journal of Epidemiology and Community Health suggest that we should be eating at least seven portions of fruit and vegetables a day.Recommendations for how many portions of fruit and vegetables people should eat varies from country to country.
Researchers find simple blood iron test predicts fatal outcomes in the general population
4/01/2014
A new study led by researchers at the Graduate Entry Medical School (GEMS), University of Limerick (UL) has found that people with low levels and very high levels of a commonly measured laboratory test, the "transferrin saturation ratio" are at an increased risk of death.
The U.S. Food and Drug Administration has approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. Alprolix is the first Hemophilia B treatment designed to require less frequent injections when used to prevent or reduce the frequency of bleeding.
New approach to leukemia testing may better define prognosis, treatment
4/01/2014
Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report.
Safety and immunogenicity of 2 doses of the HPV-16/18 AS04 adjuvanted vaccine Cervarix
4/01/2014
A recent study in the journal Human Vaccines & Immunotherapeutics, showed that two doses of the HPV-16/18 AS04-adjuvanted vaccine Cervarix (GlaxoSmithKline) are non-inferior to three-doses in the current schedule.
New predictive tool may help to determine if further cancer treatments are necessary
4/01/2014
UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model.
Adjuvant chemotherapy for breast cancer is "gerontogenic", accelerating the pace of physiologic aging, according to a new study published in the Journal of the National Cancer Institute.Loss of organ function, characterized by an increase in cellular senescence, is one physiological part of aging.
Key regulator of colon cancer discovered
4/01/2014
A team headed by Angel R. Nebreda at the Institute for Research in Biomedicine (IRB) identifies a dual role of the p38 protein in colon cancer. The study demonstrates that, on the one hand, p38 is important for the optimal maintenance of the epithelial barrier that protects the intestine against toxic agents, thus contributing to decreased tumour development.